Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(12%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
24%
Ph phase_1
1
6%
Ph phase_4
8
47%
Ph phase_3
1
6%

Phase Distribution

1

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
8(57.1%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

17

all time

Status Distribution
Active(2)
Completed(10)
Terminated(1)
Other(4)

Detailed Status

Completed10
unknown4
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 31 (7.1%)
Phase 48 (57.1%)
N/A4 (28.6%)

Trials by Status

withdrawn16%
recruiting212%
unknown424%
completed1059%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07312721Phase 4

Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

Completed
NCT02302547Phase 3

Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy

Completed
NCT02047994Phase 4

Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality

Recruiting
NCT03365609Not Applicable

A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

Recruiting
NCT04076423Phase 4

A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection

Completed
NCT05375435Phase 4

Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis

Unknown
NCT04392557Phase 4

Anti-inflammatory Status in DM2 Treated Patients

Unknown
NCT02789917Phase 4

APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF

Completed
NCT04113915

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

Unknown
NCT04006340Not Applicable

Empirical vs Tailored Therapy for H. Pylori Infection

Unknown
NCT03654781Phase 1

Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication

Completed
NCT02750631Not Applicable

Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression

Completed
NCT02881034

Ribavirin Bioavailability After Telaprevir Exposure

Completed
NCT02877199

Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy

Completed
NCT01666236Phase 4

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy

Withdrawn
NCT01306786Not Applicable

Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication

Completed
NCT02395458Phase 4

Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17